Gamma interferon, cytokine-induced macrophage activation, and antimicrobial host defense in vitro, in animal models, and in humans
- 1 September 1990
- journal article
- review article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 13 (5), 411-421
- https://doi.org/10.1016/0732-8893(90)90012-k
Abstract
No abstract availableThis publication has 51 references indexed in Scilit:
- Administration of Recombinant Interleukin-2 Reduces the Local Parasite Load of Patients with Disseminated Cutaneous LeishmaniasisThe Journal of Infectious Diseases, 1990
- Treatment of Visceral Leishmaniasis with Pentavalent Antimony and Interferon GammaNew England Journal of Medicine, 1990
- Partial Correction of the Phagocyte Defect in Patients with X-Linked Chronic Granulomatous Disease by Subcutaneous Interferon GammaNew England Journal of Medicine, 1988
- Circulating Interferon Gamma in AIDS Patients Treated with Interleukin-2New England Journal of Medicine, 1988
- Modulation of Rat Bronchoalveolar Lavage Cell Function by the Intratracheal Delivery of Interferon-γJournal of Interferon Research, 1988
- Susceptibility to murine cutaneous leishmaniasis correlates with the capacity to generate interleukin 3 in response to leishmania antigen in vitroCellular Immunology, 1988
- Local and Systemic Effects of Intradermal Recombinant Interferon-γ in Patients with Lepromatous LeprosyNew England Journal of Medicine, 1986
- Patients at Risk for AIDS-Related Opportunistic InfectionsNew England Journal of Medicine, 1985
- Impaired Production of Lymphokines and Immune (Gamma) Interferon in the Acquired Immunodeficiency SyndromeNew England Journal of Medicine, 1984
- Killing of intracellular Leishmania donovani by human mononuclear phagocytes. Evidence for oxygen-dependent and -independent leishmanicidal activity.Journal of Clinical Investigation, 1983